Ciaran Scallan

6PUBLICATIONS
8CO-AUTHORS
Molecular targetsTissue engineeringCancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of diseaseAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 08, 2024
Treatment of idiopathic pulmonary fibrosis: an update on emerging drugs in phase II & III clinical trials.

Sarah MacIsaac, Dujrath Somboonviboon, Ciaran Scallan

|Mar 14, 2023
Vascular-Parenchymal Cross-Talk Promotes Lung Fibrosis through BMPR2 Signaling.

Toyoshi Yanagihara, Kazuya Tsubouchi, Quan Zhou

|Nov 19, 2021
Connective-Tissue Growth Factor Contributes to TGF-β1-induced Lung Fibrosis.

Toyoshi Yanagihara, Kazuya Tsubouchi, Mahsa Gholiof

|Nov 17, 2021
Emerging therapeutic targets for idiopathic pulmonary fibrosis: preclinical progress and therapeutic implications.

Toyoshi Yanagihara, Ciaran Scallan, Kjetil Ask

|Jun 11, 2021
R-scale for pulmonary fibrosis: a simple, visual tool for the assessment of health-related quality of life.

Ciaran Scallan, Lauren Strand, Jennifer Hayes

|May 22, 2020
Recurrent Pulmonary Fibrosis in a Lung Allograft Secondary to De Novo Antisynthetase Syndrome.

Ciaran Scallan, Aida Venado, Lisa Han

Pageof 1